APA način citiranja

Ylösmäki, E., Ylösmäki, L., Fusciello, M., Martins, B., Ahokas, P., Cojoc, H., . . . Cerullo, V. (2021). Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform. Mol Ther Oncolytics.

Čikaški stil citiranja

Ylösmäki, Erkko, et al. "Characterization of a Novel OX40 Ligand and CD40 Ligand-expressing Oncolytic Adenovirus Used in the PeptiCRAd Cancer Vaccine Platform." Mol Ther Oncolytics 2021.

MLA način citiranja

Ylösmäki, Erkko, et al. "Characterization of a Novel OX40 Ligand and CD40 Ligand-expressing Oncolytic Adenovirus Used in the PeptiCRAd Cancer Vaccine Platform." Mol Ther Oncolytics 2021.